Ticker brief
LNTH
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
5
authors 14d
5
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-06-26 → 2026-07-02 · now -0.18 (−1 bearish … +1 bullish)
Who spoke5
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @OpenOutcrier | C | · | 1 | -0.50 |
| @OzmosiHealth | C | · | 1 | -0.50 |
| @BenzingaSpain | C | -0.88 | 1 | +0.00 |
| @BiopharmIQ | B | · | 1 | -0.50 |
| @Stockspy1 | C | +0.01 | 1 | -0.18 |
Recent signals5of 5 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-07-02 | @Stockspy1 | -0.18 | Notes LNTH is making new highs. | · | tweet ↗ |
| 2026-06-29 | @BiopharmIQ | -0.50 | FDA recap: IONS and VRDN approvals; LNTH CRL due to manufacturing facility issues. | · | tweet ↗ |
| 2026-06-29 | @BenzingaSpain | +0.00 | Lists five US stocks that could attract investor attention Monday premarket. | · | tweet ↗ |
| 2026-06-26 | @OzmosiHealth | -0.50 | Lantheus receives FDA complete response letter for LNTH-2501. | · | tweet ↗ |
| 2026-06-26 | @OpenOutcrier | -0.50 | Recaps 6/26 chatter: takeover, index inclusion, executive departure and FDA reject. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.